SCHEMBL6162665

SCHEMBL6162665

O=C(Nc1nccs1)c1c[nH]c2c(c1=O)CCCCC2

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.57
HPGD P15428 4/20 0.57
MEN1 O00255 3/20 0.57
KMT2A Q03164 3/20 0.57
LMNA P02545 3/20 0.57
RAB9A P51151 8/20 0.56
NPC1 O15118 8/20 0.56
MAPT P10636 4/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
SMN1; SMN2 Q16637 4/20 0.46
KDM4E B2RXH2 3/20 0.46
HTT P42858 3/20 0.46
PKM P14618 2/20 0.46
POLB P06746 1/20 0.46
XBP1 P17861 1/20 0.46
ALOX12 P18054 1/20 0.46
KLF5 Q13887 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
CYP1A2 P05177 2/20 0.44
GAA P10253 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6161593 0.99 ALDH1A1 (0.58) ALDH1A1HPGDMEN1KMT2ALMNA
SCHEMBL6160655 0.96 ALDH1A1 (0.55) ALDH1A1HPGDMEN1KMT2ALMNA
SCHEMBL8056224 0.82 ALDH1A1 (0.52) ALDH1A1HPGDMEN1KMT2ALMNA
SCHEMBL6161274 0.78 RAB9A (0.53) ALDH1A1HPGDMEN1KMT2ALMNA
SCHEMBL6161725 0.76 MAPT (0.41) ALDH1A1HPGDMEN1KMT2ALMNA
SCHEMBL6162104 0.76 RAB9A (0.53) ALDH1A1HPGDMEN1KMT2ALMNA
SCHEMBL6161714 0.75 MAPT (0.40) ALDH1A1MEN1KMT2ALMNARAB9A
SCHEMBL6162255 0.74 MAPT (0.41) ALDH1A1HPGDMEN1KMT2ALMNA
SCHEMBL6163600 0.73 NPC1 (0.53) MEN1KMT2ARAB9ANPC1L3MBTL1
SCHEMBL2659570 0.73 ALDH1A1 (1.00) ALDH1A1HPGDMEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1056724-B1 SUBSTITUTED CYCLOALKYL-4-OXONICOTINIC CARBOXAMIDES; GABA BRAIN RECEPTOR LIGANDS NEUROGEN CORP (US) 2005-05-25 EP claimed
US-6194427-B1 BRAIN DISORDERS; PSYCHOLOGICAL DISORDERS; SLEEP DISORDERS; ANTICONVULSANTS NEUROGEN CORPORATION 2001-02-27 US claimed
EP-1056724-B1 SUBSTITUTED CYCLOALKYL-4-OXONICOTINIC CARBOXAMIDES; GABA BRAIN RECEPTOR LIGANDS NEUROGEN CORP (US) 2005-05-25 EP disclosed
US-6448259-B1 CYCLOALKYL-4-OXONICOTINIC CARBOXAMIDES; AGONISTS, ANTAGONISTS OR INVERSE AGONISTS FOR GAMMA AMINOBUTYRIC ACID BINDING SITE, THE BENZODIAZEPINE RECEPTOR; ANXIETY, SLEEP AND SEIZURE DISORDERS SEDATIVE, ANXIOLYTIC AND ANTICONVULSANT ACTIVITY NEUROGEN CORPORATION 2002-09-10 US disclosed
US-6194427-B1 BRAIN DISORDERS; PSYCHOLOGICAL DISORDERS; SLEEP DISORDERS; ANTICONVULSANTS NEUROGEN CORPORATION 2001-02-27 US disclosed